Improvement effect of Shenshuai Yingyang Capsule on renal function and bone metabolism in renal osteodystrophy model rats and its effect on BMP-7/Smads signaling pathway
1.Department of Nephrology,Hospital of integrated Traditional Chinese and Western Medicine,Southern Medical University,Guangzhou 510315,China 2.Department of Traditional Chinese Internal Medicine,School of Traditional Chinese Medicine,Southern Medical University,Guangzhou 510515,China 3.Department of Traditional Chinese Medicine,Shenzhen Hospital,Southern Medical University,Shenzhen 518000,China
Jiebin CHEN,Rong HU,Peijia LYU,Chengjie LI,Lianbo WEI. Improvement effect of Shenshuai Yingyang Capsule on renal function and bone metabolism in renal osteodystrophy model rats and its effect on BMP-7/Smads signaling pathway[J].Journal of Jilin University(Medicine Edition), 2024, 50(3): 658-665.
Pathomorphology of femur tissue of rats in various groups (HE, ×400)"
Fig. 1
Tab.1
Levels of BUN and Scr in serum of rats in various groups"
Group
BUN[cB/(mmol·L-1)]
Scr[cB/(μmol·L-1)]
Control
5.36±0.64
27.95±3.88
Model
17.28±2.53*
171.25±25.03*
Positive control
14.32±2.34△
123.18±21.14△
Shenshuai Yingyang Capsule
11.36±2.10△#
68.36±7.54△#
Tab.1
Tab.2
Levels of Ca2+, P3-, PTH, and ALP in serum of rats in various groups"
Group
Ca2+[cB/(mmol·L-1)]
P3-[cB/(mmol·L-1)]
PTH[ρB/(ng·L-1)]
ALP[λB/(U·L-1)]
Control
2.35±0.35
1.15±0.20
1.42±0.23
36.52±4.33
Model
1.78±0.25*
3.18±0.41*
3.52±0.45*
79.55±8.74*
Positive control
1.94±0.29△
2.61±0.34△
2.44±0.34△
61.02±7.18△
Shenshuai Yingyang Capsule
2.28±0.33△#
2.25±0.31△#
1.85±0.32△#
48.39±5.47△#
Tab.2
Tab.3
BMD and bone volume fractions of femur of rats in various groups"
Group
BMD(g·cm-2)
Bone volume fraction(η/%)
Control
0.18±0.04
0.57±0.06
Model
0.11±0.01*
0.31±0.03*
Positive control
0.13±0.02△
0.39±0.04△
Shenshuai Yingyang Capsule
0.16±0.03△#
0.48±0.05△#
Tab.3
Tab.4
Expression levels of BMP-7 and Smad1/5/8 mRNA in femur tissue of rats in various groups"
Group
BMP-7 mRNA
Smad1/5/8 mRNA
Control
1.00±0.01
1.00±0.01
Model
0.32±0.04*
0.33±0.04*
Positive control
0.51±0.06△
0.68±0.07△
Shenshuai Yingyang Capsule
0.84±0.09△#
0.82±0.09△#
Tab.4
Fig.2
Electrophoregram of expressions of BMP-7, p-BMP-7, Smad 1/5/8, and p-Smad 1/5/8 proteins in femur tissue of rats in various groups detected by Western blotting method"
Fig.2
Tab.5
Expression levels of BMP-7, p-BMP-7, Smad1/5/8, and p-Smad1/5/8 proteins in femur tissue of rats in various groups"
PAZIANAS M, MILLER P D. Osteoporosis and chronic kidney disease-mineral and bone disorder (CKD-MBD): back to basics[J]. Am J Kidney Dis, 2021, 78(4): 582-589.
2
CANNATA-ANDA J B, MARTN-CARRO B, MARTN-VRGALA J, et al. Chronic kidney disease-mineral and bone disorders: pathogenesis and management[J]. Calcif Tissue Int, 2021, 108(4): 410-422.
3
GINSBERG C, IX J H. Diagnosis and management of osteoporosis in advanced kidney disease: a review[J]. Am J Kidney Dis, 2022, 79(3): 427-436.
PEREIRA L, MAGALHÃES J, MENDONÇA L, et al. Evaluation of renal osteodystrophy and serum bone-related biomarkers in a peritoneal dialysis population[J]. J Bone Miner Res, 2022, 37(9): 1689-1699.
8
EVENEPOEL P, CUNNINGHAM J, FERRARI S, et al. European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D[J]. Nephrol Dial Transplant, 2021, 36(1): 42-59.
9
JØRGENSEN H S, BEHETS G, BAMMENS B, et al. Patterns of renal osteodystrophy 1 year after kidney transplantation[J]. Nephrol Dial Transplant, 2021, 36(11): 2130-2139.
10
ABDALBARY M, SOBH M, ELNAGAR S, et al. Management of osteoporosis in patients with chronic kidney disease[J]. Osteoporos Int, 2022, 33(11): 2259-2274.
SHATAGOPAM K, BAHLER C D, SUNDARAM C P. Renorrhaphy techniques and effect on renal function with robotic partial nephrectomy[J]. World J Urol, 2020, 38(5): 1109-1112.
15
SÁNCHEZ ARCO A M, SEGURA JIMÉNEZ I, PLATA ILLESCAS C, et al. Renal function in receptors with simultaneous liver-kidney transplant from the same donor[J]. Transplant Proc, 2022, 54(1): 45-47.